Overview
Chul Park practices in Seoul, Republic of Korea. Park is rated as an Experienced expert by MediFind in the treatment of Pica. Their top areas of expertise are Pneumonia, Chronic Eosinophilic Pneumonia, Simple Pulmonary Eosinophilia, and Eosinophilic Pneumonia.
Their clinical research consists of co-authoring 39 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Pica.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cardiac ArrestPark isExperienced. Learn about Cardiac Arrest.
- Chronic Eosinophilic Pneumonia
- COVID-19Park isExperienced. Learn about COVID-19.
- Eosinophilic PneumoniaPark isExperienced. Learn about Eosinophilic Pneumonia.
- Hospital-Acquired PneumoniaPark isExperienced. Learn about Hospital-Acquired Pneumonia.
- Hypereosinophilic SyndromePark isExperienced. Learn about Hypereosinophilic Syndrome.